首页
热心肠日报
文献库
产业库
榜单
关于日报
《肠·道》演讲
往期精彩
《肠·道》2024
《肠·道》2023
《肠·道》2022
《肠·道》2021
《肠·道》2020
《肠·道》2019
《肠·道》2018
《肠·道》2017
关于《肠·道》
肠道大会
热心肠大会
热心肠智库
智库专家
专家动态
智库新闻
关于智库
奖学金
年度人物奖
更多
HOPE
会议信息
科学与艺术
学术专刊
R·AI
周刊
热心肠先生
研究院动态
关于我们
搜索
登录
关闭
手机邮箱登录
扫码登录
微信扫描二维码快捷登录
验证成功,将在
3
秒钟后跳转
已超时,请
重试
关闭
二维码登录
手机登录
邮箱登录
+86
+1
+852
+886
+81
+65
+61
+44
获取验证码
登录 / 注册
关闭
二维码登录
手机登录
邮箱登录
获取验证码
登录 / 注册
热心肠智库
专家文章 | 朱瑞新
2024
CA
Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer
PHYSIOL GENOMICS, 10.1152/physiolgenomics.00103.2023
CA
Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis
Commun Biol, 10.1038/s42003-023-05714-0
2023
CA
Evidence challenging the causal role of gut microbiota in inflammatory bowel diseases
GASTROENTEROL REP, 10.1093/gastro/goad064
CA
Multimodal metagenomic analysis reveals microbial single nucleotide variants as superior biomarkers for early detection of colorectal cancer
Gut Microbes, 10.1080/19490976.2023.2245562
点击查看热心肠日报解读
FA
Toward the Understanding of Altered Gut Microbiome in Crohn's Disease: Cause or Consequence
Gastroenterology, 10.1053/j.gastro.2023.06.015
CA
NAFLDkb: A Knowledge Base and Platform for Drug Development against Nonalcoholic Fatty Liver Disease
J CHEM INF MODEL, 10.1021/acs.jcim.3c00395
CA
Integrative multi-omics deciphers the spatial characteristics of host-gut microbiota interactions in Crohn's disease
CELL REP MED, 10.1016/j.xcrm.2023.101050
点击查看热心肠日报解读
2022
CA
IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
FPHAR, 10.3389/fphar.2022.869200
CA
IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
FPHAR, 10.3389/fphar.2022.869200
CA
IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
FPHAR, 10.3389/fphar.2022.869200
CA
IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
FPHAR, 10.3389/fphar.2022.869200
CA
IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
FPHAR, 10.3389/fphar.2022.869200
CA
IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC
FPHAR, 10.3389/fphar.2022.869200
CA
Multi-kingdom microbiota analyses identify bacterial-fungal interactions and biomarkers of colorectal cancer across cohorts
Nat Microbiol, 10.1038/s41564-021-01030-7
点击查看热心肠日报解读
2021
CA
Alterations in bile acid metabolizing gut microbiota and specific bile acid genes as a precision medicine to subclassify NAFLD
PHYSIOL GENOMICS, 10.1152/physiolgenomics.00011.2021
CA
Identification of microbial markers across populations in early detection of colorectal cancer
Nat Commun, 10.1038/s41467-021-23265-y
SA
Gastrointestinal sequelae 90 days after discharge for COVID-19
LANCET GASTROENTEROL, 10.1016/S2468-1253(21)00076-5
点击查看热心肠日报解读
CA
Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study
FRONT MED-LAUSANNE, 10.3389/fmed.2021.604263
CA
Metagenomic analysis of the salivary microbiota in patients with caries, periodontitis and comorbid diseases
J DENT SCI, 10.1016/j.jds.2020.12.002
2020
CA
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study
RESP RES, 10.1186/s12931-020-01492-z